Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Select category
Search this blog
The Value of Drug–Drug Interaction Risk Assessments
Posted on June 28th, 2017 by Sherry Winter in Pharma R&D
Should a drug candidate move on to pre-clinical and clinical trials? It’s a question that every pharmaceutical developer must face, and the earlier they can answer it, the better in terms of use of time and effort. (more…)
